Eli Lilly & Co (LLY) - Revenue Change due to FX (I:ELCLMS4H)
Level Chart
Basic Info
|
Eli Lilly & Co (LLY) - Revenue Change due to FX is at -1.00%, compared to 0.00% last quarter and -1.00% last year. This is lower than the long term average of -0.47%. |
|
Revenue Change due to FX refers to the percentage change in the company's total revenue that is attributed to fluctuations in foreign exchange (FX) rates. This metric helps investors, analysts, and stakeholders understand the impact of changes in currency exchange rates on Eli Lilly & Co's overall revenue growth or decline. |
| Report | FinChat.io |
| Category | Segments & KPIs |
| Region | United States |
| Source | FinChat.io |
|
Data provided via FinChat.io |
Stats
| Last Value | -1.00% |
| Latest Period | Jun 2024 |
| Last Updated | Aug 30 2024, 08:33 EDT |
| Next Release | Nov 29 2024, 08:30 EST (E) |
| Long Term Average | -0.47% |
| Average Growth Rate | -120.8% |
| Value from Last Quarter | 0.00% |
| Change from Last Quarter | N/A |
| Value from 1 Year Ago | -1.00% |
| Change from 1 Year Ago | N/A |
| Frequency | Quarterly |
| Unit | Percent |
| Adjustment | N/A |
Historical Data
| Date | Value |
|---|---|
| June 30, 2024 | -1.00% |
| March 31, 2024 | 0.00% |
| December 31, 2023 | 1.00% |
| September 30, 2023 | 1.00% |
| June 30, 2023 | -1.00% |
| March 31, 2023 | -2.00% |
| December 31, 2022 | -4.00% |
| September 30, 2022 | -4.00% |
| June 30, 2022 | -3.00% |
| March 31, 2022 | -2.00% |
| Date | Value |
|---|---|
| December 31, 2021 | 0.00% |
| September 30, 2021 | 1.00% |
| June 30, 2021 | 3.00% |
| March 31, 2021 | 3.00% |
| December 31, 2020 | 1.00% |
| September 30, 2020 | 1.00% |
| June 30, 2020 | -1.00% |
| March 31, 2020 | -1.00% |
| December 31, 2019 | -1.00% |
News
Basic Info
|
Eli Lilly & Co (LLY) - Revenue Change due to FX is at -1.00%, compared to 0.00% last quarter and -1.00% last year. This is lower than the long term average of -0.47%. |
|
Revenue Change due to FX refers to the percentage change in the company's total revenue that is attributed to fluctuations in foreign exchange (FX) rates. This metric helps investors, analysts, and stakeholders understand the impact of changes in currency exchange rates on Eli Lilly & Co's overall revenue growth or decline. |
| Report | FinChat.io |
| Category | Segments & KPIs |
| Region | United States |
| Source | FinChat.io |
|
Data provided via FinChat.io |
Stats
| Last Value | -1.00% |
| Latest Period | Jun 2024 |
| Last Updated | Aug 30 2024, 08:33 EDT |
| Next Release | Nov 29 2024, 08:30 EST (E) |
| Long Term Average | -0.47% |
| Average Growth Rate | -120.8% |
| Value from Last Quarter | 0.00% |
| Change from Last Quarter | N/A |
| Value from 1 Year Ago | -1.00% |
| Change from 1 Year Ago | N/A |
| Frequency | Quarterly |
| Unit | Percent |
| Adjustment | N/A |